1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends
  4. > Pathology Analysis & Statistics 2022 - Europe (p2)

Pathology Analysis & Statistics 2022 - Europe (p2)

Customer Support

Talk to Ahmad

+1 718 618 4302

Publishers

  • All
    • Global Markets Direct

All regions

31-60 of about 100 reports

Peanut Allergy (Immunology) - Drugs In Development, 2021

  • $ 2000
  • July 2021
  • 176 pages

Peanut Allergy (Immunology) - Drugs In Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Peanut Allergy - Drugs In Development, 2021, provides an overview of the ...

  • World
  • United Kingdom
  • Allergy
  • Drug Development
  • Industry analysis
  • Pharmaceutical Registrations
  • Dropout Rate

Myocarditis (Cardiovascular) - Drugs In Development, 2021

  • $ 2000
  • June 2021
  • 57 pages

Myocarditis (Cardiovascular) - Drugs In Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Myocarditis (Cardiovascular) - Drugs In Development, 2021, provides an ...

  • World
  • Sweden
  • Cardiovascular Disease
  • Drug Development
  • Industry analysis
  • Child Mortality
  • Hospital Discharge

Dilated Cardiomyopathy (Cardiovascular) - Drugs in Development, 2021

  • $ 2000
  • March 2021
  • 71 pages

Dilated Cardiomyopathy (Cardiovascular) - Drugs in Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Dilated Cardiomyopathy - Drugs in Development, 2021, provides ...

  • World
  • Germany
  • Cardiovascular Disease
  • Cardiology
  • Industry analysis
  • Surgical Procedures Performed
  • Drug Approval

Smallpox (Infectious Disease) - Drugs in Development, 2021

  • $ 2000
  • March 2021
  • 88 pages

Smallpox (Infectious Disease) - Drugs in Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Smallpox - Drugs in Development, 2021, provides an overview of the Smallpox ...

  • World
  • Northern Europe
  • Infectious Disease
  • Industry analysis
  • Mortality Rate
  • Manufacturing Orders

Amyloidosis (Metabolic Disorder) - Drugs in Development, 2021

  • $ 2000
  • March 2021
  • 304 pages

Amyloidosis (Metabolic Disorder) - Drugs in Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Amyloidosis - Drugs in Development, 2021, provides an overview of ...

  • World
  • United Kingdom
  • Therapy
  • Pharmaceutical
  • Industry analysis
  • Stem Cell Transplantation
  • Pharmaceutical Registrations

Islet Amyloid Polypeptide (Amylin or Diabetes Associated Peptide or Insulinoma Amyloid Peptide or IAPP) - Drugs in Development, 2021

  • $ 3500
  • March 2021
  • 63 pages

Islet Amyloid Polypeptide (Amylin or Diabetes Associated Peptide or Insulinoma Amyloid Peptide or IAPP) - Drugs in Development, 2021 Summary Islet Amyloid Polypeptide (Amylin or Diabetes Associated Peptide ...

  • World
  • Northern Europe
  • Therapy
  • Pharmaceutical
  • Industry analysis
  • Diabetes Prevalence
  • Food Consumption

Lysosomal Alpha Glucosidase (Acid Maltase or Aglucosidase Alfa or GAA or EC 3.2.1.20) - Drugs in Development, 2021

  • $ 3500
  • March 2021
  • 87 pages

Lysosomal Alpha Glucosidase (Acid Maltase or Aglucosidase Alfa or GAA or EC 3.2.1.20) - Drugs in Development, 2021 Summary According to the recently published report ’Lysosomal Alpha Glucosidase - Drugs ...

  • World
  • Belgium
  • Neurological Disorder
  • Therapy
  • Industry analysis
  • Number Of R&D Personnel
  • Pharmaceutical Exports

Interleukin 1 (IL1) - Drugs in Development, 2021

  • $ 3500
  • March 2021
  • 162 pages

Interleukin 1 (IL1) - Drugs in Development, 2021 Summary According to the recently published report ’Interleukin 1 - Drugs in Development, 2021’; Interleukin 1 (IL1) pipeline Target constitutes close ...

  • World
  • United Kingdom
  • Pathology
  • Pharmaceutical
  • Industry analysis
  • Drug Approval
  • Pharmaceutical Registrations

Rubella (German Measles) - Pipeline Review, H2 2020

  • $ 2000
  • November 2020
  • 45 pages

Rubella (German Measles) - Pipeline Review, H2 2020 Summary latest Pharmaceutical and Healthcare disease pipeline guide Rubella - Pipeline Review, H2 2020, provides an overview of the Rubella (Infectious ...

  • Germany
  • Infectious Disease
  • Industry analysis
  • Infectious Disease Prevalence
  • Health Provider Density

Respiratory Syncytial Virus (RSV) Infections - Pipeline Review, H2 2020

  • $ 2000
  • November 2020
  • 319 pages

Respiratory Syncytial Virus (RSV) Infections - Pipeline Review, H2 2020 Summary latest Pharmaceutical and Healthcare disease pipeline guide Respiratory Syncytial Virus Infections - Pipeline Review, ...

  • Northern Europe
  • Infectious Disease
  • Industry analysis
  • Drug Approval
  • Child Mortality

Yellow Fever - Pipeline Review, H2 2020

  • $ 2500
  • October 2020
  • 71 pages

Yellow Fever - Pipeline Review, H2 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Yellow Fever - Pipeline Review, H2 2020, provides an overview of the Yellow Fever (Infectious ...

  • World
  • Northern Europe
  • Infectious Disease
  • Industry analysis
  • Cause-Specific Mortality Rate
  • Hospital Discharge

Post Menopausal Osteoporosis - Pipeline Review, H2 2020

  • $ 2000
  • October 2020
  • 131 pages

Post Menopausal Osteoporosis - Pipeline Review, H2 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Post Menopausal Osteoporosis - Pipeline Review, H2 2020, provides an ...

  • World
  • Shandong
  • Musculoskeletal Disorder
  • Industry analysis
  • Pharmaceutical Registrations
  • Number Of R&D Personnel

Epidermolysis Bullosa - Pipeline Review, H2 2020

  • $ 2000
  • October 2020
  • 170 pages

Epidermolysis Bullosa - Pipeline Review, H2 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Epidermolysis Bullosa - Pipeline Review, H2 2020, provides an overview of the ...

  • World
  • Spain
  • Dermatological Condition
  • Industry analysis
  • Pharmaceutical Registrations
  • Mortality Rate

Cystic Fibrosis - Pipeline Review, H2 2020

  • $ 2500
  • October 2020
  • 550 pages

Cystic Fibrosis - Pipeline Review, H2 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Cystic Fibrosis - Pipeline Review, H2 2020, provides an overview of the Cystic Fibrosis ...

  • Europe
  • World
  • Cystic Fibrosis
  • Company research
  • Company

Pompe Disease - Pipeline Review, H2 2020

  • $ 2000
  • October 2020
  • 104 pages

Pompe Disease - Pipeline Review, H2 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Pompe Disease - Pipeline Review, H2 2020, provides an overview of the Pompe Disease ...

  • World
  • Belgium
  • Neurological Disorder
  • Industry analysis
  • Number Of R&D Personnel
  • Pharmaceutical Exports

Peanut Allergy - Pipeline Review, H2 2020

  • $ 2000
  • October 2020
  • 170 pages

Peanut Allergy - Pipeline Review, H2 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Peanut Allergy - Pipeline Review, H2 2020, provides an overview of the Peanut Allergy ...

  • World
  • United Kingdom
  • Allergy
  • Industry analysis
  • Pharmaceutical Registrations
  • Dropout Rate

Human Papillomavirus (HPV) Associated Cancer - Pipeline Review, H2 2020

  • $ 2000
  • September 2020
  • 386 pages

Human Papillomavirus (HPV) Associated Cancer - Pipeline Review, H2 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Human Papillomavirus (HPV) Associated Cancer - Pipeline ...

  • United States
  • World
  • Cancer
  • Sexually Transmitted Disease
  • Industry analysis
  • Smoking Prevalence
  • Pharmaceutical Registrations

Influenza A Virus, H5N1 Subtype Infections - Pipeline Review, H2 2020

  • $ 2000
  • September 2020
  • 192 pages

Influenza A Virus, H5N1 Subtype Infections - Pipeline Review, H2 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Influenza A Virus, H5N1 Subtype Infections - Pipeline ...

  • World
  • Netherlands
  • Influenza
  • Industry analysis
  • Health Provider Density
  • Drug Approval

Ebolavirus Infections (Ebola Hemorrhagic Fever) - Pipeline Review, H2 2020

  • $ 2000
  • September 2020
  • 342 pages

Ebolavirus Infections (Ebola Hemorrhagic Fever) - Pipeline Review, H2 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Ebolavirus Infections (Ebola Hemorrhagic Fever) - ...

  • Germany
  • Infectious Disease
  • Industry analysis
  • Mortality Rate
  • Drug Approval

Epstein-Barr Virus (HHV-4) Infections - Pipeline Review, H2 2020

  • $ 2000
  • September 2020
  • 209 pages

Epstein-Barr Virus (HHV-4) Infections - Pipeline Review, H2 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Epstein-Barr Virus (HHV-4) Infections - Pipeline Review, H2 ...

  • World
  • China
  • Infectious Disease
  • Industry analysis
  • Pharmaceutical Registrations
  • Stem Cell Transplantation

Polycythemia Vera - Pipeline Review, H2 2020

  • $ 2000
  • August 2020
  • 132 pages

Polycythemia Vera - Pipeline Review, H2 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Polycythemia Vera - Pipeline Review, H2 2020, provides an overview of the Polycythemia ...

  • Spain
  • Therapy
  • Blood Disease
  • Industry analysis
  • Smoking Prevalence
  • Pharmaceutical Registrations

B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H2 2020

  • $ 2000
  • August 2020
  • 211 pages

B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H2 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H2 2020, ...

  • World
  • Northern Europe
  • Immunotherapy
  • Leukemia
  • Industry analysis
  • Cause-Specific Mortality Rate
  • Stem Cell Transplantation

Myocarditis - Pipeline Review, H2 2020

  • $ 2000
  • August 2020
  • 50 pages

Myocarditis - Pipeline Review, H2 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Myocarditis - Pipeline Review, H2 2020, provides an overview of the Myocarditis (Cardiovascular) ...

  • World
  • Sweden
  • Therapy
  • Cardiovascular Disease
  • Industry analysis
  • Child Mortality
  • Drug Approval

Thalassemia - Pipeline Review, H2 2020

  • $ 2000
  • August 2020
  • 215 pages

Thalassemia - Pipeline Review, H2 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Thalassemia - Pipeline Review, H2 2020, provides an overview of the Thalassemia (Hematological ...

  • World
  • Spain
  • Blood Disease
  • Industry analysis
  • Stem Cell Transplantation
  • Drug Approval

Influenza A Virus, H3N2 Subtype Infections - Pipeline Review, H2 2020

  • $ 2000
  • August 2020
  • 163 pages

Influenza A Virus, H3N2 Subtype Infections - Pipeline Review, H2 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Influenza A Virus, H3N2 Subtype Infections - Pipeline ...

  • World
  • Netherlands
  • Influenza
  • Industry analysis
  • Drug Approval
  • Elderly Population

Prostate Specific Antigen - Pipeline Review, H2 2020

  • $ 3500
  • August 2020
  • 82 pages

Prostate Specific Antigen - Pipeline Review, H2 2020 Summary According to the recently published report ’Prostate Specific Antigen - Pipeline Review, H2 2020’; Prostate Specific Antigen (Gamma ...

  • World
  • Northern Europe
  • Prostate Cancer
  • Industry analysis
  • Drug Approval
  • Lead Price

Smallpox - Pipeline Review, H2 2020

  • $ 2000
  • July 2020
  • 85 pages

Smallpox - Pipeline Review, H2 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Smallpox - Pipeline Review, H2 2020, provides an overview of the Smallpox (Infectious Disease) ...

  • World
  • Northern Europe
  • Infectious Disease
  • Industry analysis
  • Mortality Rate
  • Manufacturing Orders

Amyloidosis - Pipeline Review, H2 2020

  • $ 2000
  • July 2020
  • 241 pages

Amyloidosis - Pipeline Review, H2 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Amyloidosis - Pipeline Review, H2 2020, provides an overview of the Amyloidosis (Metabolic ...

  • World
  • Sweden
  • Therapy
  • Endocrine Disease
  • Industry analysis
  • Stem Cell Transplantation
  • Pharmaceutical Registrations

Dilated Cardiomyopathy - Pipeline Review, H2 2020

  • $ 2000
  • July 2020
  • 66 pages

Dilated Cardiomyopathy - Pipeline Review, H2 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Dilated Cardiomyopathy - Pipeline Review, H2 2020, provides an overview of ...

  • World
  • Germany
  • Cardiovascular Disease
  • Cardiology
  • Industry analysis
  • Surgical Procedures Performed
  • Drug Approval

Transforming Growth Factor Beta 1 - Pipeline Review, H2 2020

  • $ 3500
  • July 2020
  • 102 pages

Transforming Growth Factor Beta 1 - Pipeline Review, H2 2020 Summary Transforming Growth Factor Beta 1 (TGFB1) - Transforming growth factor beta 1 (TGF-?1) is a polypeptide member of the transforming ...

  • World
  • United States
  • Pharmaceutical
  • Therapy
  • Industry analysis

Reportlinker.com © Copyright 2022. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on